AMPH Amphastar Pharmaceuticals Inc
1,110
$42.43
$0.25
(0.59%)
| Watchers | 1,110 |
| 52-Wk Low | $36.06 |
| 52-Wk High | $67.66 |
| Market Cap | $2.07B |
| Volume | 6,367.00 |
| 52-Wk High | $67.66 |
| 52-Wk Low | $36.06 |
Amphastar Pharmaceuticals Interested In Potential Acquisitions In Endocrinology-Focused CompaniesBenzinga • 27 days ago
Amphastar Pharmaceuticals discusses the future of Baqsimi at the Needham Healthcare Conference, highlighting its potential amid a growing market for glucagon products. With promising sales...
Share to Feed
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Get Free Report) Director Floyd F. Petersen sold 500 shares of the firm's stock in a transaction that occurred on Monday, April 1st. The stock was sold...
RANCHO CUCAMONGA, CA / ACCESSWIRE / April 1, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, Tony Marrs, EVP of Regulatory Affairs and Clinical Operations...
Advisor Resource Council bought a new stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH Free Report) during the fourth quarter, Holdings Channel.com reports. The fund bought...
This is a Bullish indicator signaling AMPH's price could rise from here. Traders may explore going long the stock or buying call options...
This is a signal that AMPH's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...
Lido Advisors LLC lowered its holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH Free Report) by 26.0% in the third quarter, according to the company in its most recent Form 13F filing...
This is a signal that AMPH's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...
JPMorgan Chase Co. initiated coverage on shares of Amphastar Pharmaceuticals (NASDAQ:AMPH Free Report) in a report issued on Tuesday morning, MarketBeat reports. The brokerage issued an...
This is a signal that AMPH's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...